{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:52:45Z","timestamp":1790747565262,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:00:00Z","timestamp":1566345600000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ophtha.2018.04.001","type":"journal-article","created":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T02:54:57Z","timestamp":1526007297000},"page":"1421-1430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"title":["Clustered Regularly Interspaced Short Palindromic Repeats-Based Genome Surgery for the Treatment of Autosomal Dominant Retinitis Pigmentosa"],"prefix":"10.1016","volume":"125","author":[{"given":"Yi-Ting","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hsuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Pu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Justus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyuan-Sheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Jauregui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9549","key":"10.1016\/j.ophtha.2018.04.001_bib1","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","article-title":"Retinitis pigmentosa","volume":"368","author":"Hartong","year":"2006","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ophtha.2018.04.001_bib2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017400","article-title":"Gene augmentation for adRP mutations in RHO","volume":"4","author":"Lewin","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"10.1016\/j.ophtha.2018.04.001_bib3","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/mt.2010.293","article-title":"Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa","volume":"19","author":"Millington-Ward","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.ophtha.2018.04.001_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-4614-0631-0_26","article-title":"Functional rescue of P23H rhodopsin photoreceptors by gene delivery","volume":"723","author":"Gorbatyuk","year":"2012","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.ophtha.2018.04.001_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.exer.2006.08.014","article-title":"Preservation of photoreceptor morphology and function in P23H rats using an allele independent ribozyme","volume":"84","author":"Gorbatyuk","year":"2007","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ophtha.2018.04.001_bib6","first-page":"648","article-title":"Knockdown of wild-type mouse rhodopsin using an AAV vectored ribozyme as part of an RNA replacement approach","volume":"11","author":"Gorbatyuk","year":"2005","journal-title":"Mol Vis"},{"issue":"4","key":"10.1016\/j.ophtha.2018.04.001_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1089\/hum.2011.213","article-title":"Long-term rescue of retinal structure and function by rhodopsin RNA replacement with a single adeno-associated viral vector in P23H RHO transgenic mice","volume":"23","author":"Mao","year":"2012","journal-title":"Hum Gene Ther"},{"issue":"3","key":"10.1016\/j.ophtha.2018.04.001_bib8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/mt.2015.220","article-title":"In\u00a0vivo CRISPR\/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa","volume":"24","author":"Bakondi","year":"2016","journal-title":"Mol Ther"},{"issue":"11","key":"10.1016\/j.ophtha.2018.04.001_bib9","article-title":"In\u00a0vivo editing of the human mutant rhodopsin gene by electroporation of plasmid-based CRISPR\/Cas9 in the mouse retina","volume":"5","author":"Latella","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6096","key":"10.1016\/j.ophtha.2018.04.001_bib10","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A\u00a0programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"issue":"6121","key":"10.1016\/j.ophtha.2018.04.001_bib11","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ophtha.2018.04.001_bib12","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat Protoc"},{"issue":"7","key":"10.1016\/j.ophtha.2018.04.001_bib13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.dnarep.2013.04.024","article-title":"Repair of chromosomal double-strand breaks by precise ligation in human cells","volume":"12","author":"Lin","year":"2013","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.ophtha.2018.04.001_bib14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2119\/molmed.2011.00475","article-title":"Mice with a D190N mutation in the gene encoding rhodopsin: a model for human autosomal-dominant retinitis pigmentosa","volume":"18","author":"Sancho-Pelluz","year":"2012","journal-title":"Mol Med"},{"issue":"4","key":"10.1016\/j.ophtha.2018.04.001_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molmed.2005.02.007","article-title":"Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy","volume":"11","author":"Mendes","year":"2005","journal-title":"Trends Mol Med"},{"issue":"11","key":"10.1016\/j.ophtha.2018.04.001_bib16","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1080\/02713680802484645","article-title":"Phenotype-genotype correlations in autosomal dominant retinitis pigmentosa caused by RHO, D190N","volume":"33","author":"Tsui","year":"2008","journal-title":"Curr Eye Res"},{"issue":"24","key":"10.1016\/j.ophtha.2018.04.001_bib17","doi-asserted-by":"crossref","first-page":"17698","DOI":"10.1074\/jbc.M112.397257","article-title":"Thermal stability of rhodopsin and progression of retinitis pigmentosa: comparison of S186W and D190N rhodopsin mutants","volume":"288","author":"Liu","year":"2013","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"10.1016\/j.ophtha.2018.04.001_bib18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3928\/23258160-20140908-01","article-title":"Early structural anomalies observed by high-resolution imaging in two related cases of autosomal-dominant retinitis pigmentosa","volume":"45","author":"Park","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"12","key":"10.1016\/j.ophtha.2018.04.001_bib19","doi-asserted-by":"crossref","first-page":"10551","DOI":"10.1074\/jbc.M110.209759","article-title":"Probing mechanisms of photoreceptor degeneration in a new mouse model of the common form of autosomal dominant retinitis pigmentosa due to P23H opsin mutations","volume":"286","author":"Sakami","year":"2011","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.ophtha.2018.04.001_bib20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1089\/hum.2015.147","article-title":"Let there be light: gene and cell therapy for blindness","volume":"27","author":"Dalkara","year":"2016","journal-title":"Hum Gene Ther"},{"issue":"4","key":"10.1016\/j.ophtha.2018.04.001_bib21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3727\/096368916X690863","article-title":"Allele-specific reduction of the mutant huntingtin allele using transcription activator-like effectors in human Huntington\u2019s disease fibroblasts","volume":"25","author":"Fink","year":"2016","journal-title":"Cell Transplant"},{"issue":"25","key":"10.1016\/j.ophtha.2018.04.001_bib22","doi-asserted-by":"crossref","first-page":"9253","DOI":"10.1073\/pnas.1323941111","article-title":"Targeted inversion and reversion of the blood coagulation factor 8 gene in human iPS cells using TALENs","volume":"111","author":"Park","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"10.1016\/j.ophtha.2018.04.001_bib23","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1182\/blood-2013-04-497354","article-title":"Robust ZFN-mediated genome editing in adult hemophilic mice","volume":"122","author":"Anguela","year":"2013","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.ophtha.2018.04.001_bib24","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1182\/blood-2014-12-615948","article-title":"Correction of the sickle cell disease mutation in human hematopoietic stem\/progenitor cells","volume":"125","author":"Hoban","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ophtha.2018.04.001_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s13238-017-0397-3","article-title":"CRISPR\/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs","volume":"8","author":"Wang","year":"2017","journal-title":"Protein Cell"},{"key":"10.1016\/j.ophtha.2018.04.001_bib26","doi-asserted-by":"crossref","first-page":"14454","DOI":"10.1038\/ncomms14454","article-title":"Muscle-specific CRISPR\/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy","volume":"8","author":"Bengtsson","year":"2017","journal-title":"Nat Commun"},{"issue":"6201","key":"10.1016\/j.ophtha.2018.04.001_bib27","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.1254445","article-title":"Prevention of muscular dystrophy in mice by CRISPR\/Cas9-mediated editing of germline DNA","volume":"345","author":"Long","year":"2014","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ophtha.2018.04.001_bib28","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.ymthe.2017.08.015","article-title":"Cut and paste: efficient homology-directed repair of a dominant negative KRT14 mutation via CRISPR\/Cas9 nickases","volume":"25","author":"Kocher","year":"2017","journal-title":"Mol Ther"},{"issue":"6271","key":"10.1016\/j.ophtha.2018.04.001_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In\u00a0vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"issue":"6271","key":"10.1016\/j.ophtha.2018.04.001_bib30","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In\u00a0vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Science"},{"issue":"6271","key":"10.1016\/j.ophtha.2018.04.001_bib31","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy","volume":"351","author":"Long","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ophtha.2018.04.001_bib32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1086\/519025","article-title":"RNA interference-mediated suppression and replacement of human rhodopsin in\u00a0vivo","volume":"81","author":"O\u2019Reilly","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.ophtha.2018.04.001_bib33","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.visres.2007.08.014","article-title":"A\u00a0transgenic mouse model for gene therapy of rhodopsin-linked retinitis pigmentosa","volume":"48","author":"O\u2019Reilly","year":"2008","journal-title":"Vision Res"},{"issue":"31","key":"10.1016\/j.ophtha.2018.04.001_bib34","doi-asserted-by":"crossref","first-page":"30675","DOI":"10.18632\/oncotarget.5169","article-title":"Progresses towards safe and efficient gene therapy vectors","volume":"6","author":"Chira","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ophtha.2018.04.001_bib35","doi-asserted-by":"crossref","first-page":"10416","DOI":"10.1038\/s41598-017-10966-y","article-title":"Impact of different promoters, promoter mutation, and an enhancer on recombinant protein expression in CHO cells","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ophtha.2018.04.001_bib36","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.stem.2014.10.004","article-title":"Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR\/Cas9","volume":"15","author":"Mandal","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.ophtha.2018.04.001_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004086","article-title":"Is non-homologous end-joining really an inherently error-prone process?","volume":"10","author":"Betermier","year":"2014","journal-title":"PLoS Genet"},{"issue":"7631","key":"10.1016\/j.ophtha.2018.04.001_bib38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nature20565","article-title":"In\u00a0vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ophtha.2018.04.001_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrd3010","article-title":"Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application","volume":"9","author":"Jackson","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ophtha.2018.04.001_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2015.23","article-title":"siRNA Versus miRNA as therapeutics for gene silencing","volume":"4","author":"Lam","year":"2015","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"10.1016\/j.ophtha.2018.04.001_bib41","first-page":"175","article-title":"RNAi off-targeting: light at the end of the tunnel","volume":"2","author":"Brown","year":"2006","journal-title":"J\u00a0RNAi Gene Silencing"},{"issue":"1","key":"10.1016\/j.ophtha.2018.04.001_bib42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrc2966","article-title":"RNA interference in the clinic: challenges and future directions","volume":"11","author":"Pecot","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.ophtha.2018.04.001_bib43","first-page":"187","article-title":"Therapeutic siRNA: principles, challenges, and strategies","volume":"85","author":"Gavrilov","year":"2012","journal-title":"Yale J Biol Med"},{"issue":"6","key":"10.1016\/j.ophtha.2018.04.001_bib44","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nbt.3536","article-title":"CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes","volume":"34","author":"Evers","year":"2016","journal-title":"Nat Biotechnol"},{"issue":"6166","key":"10.1016\/j.ophtha.2018.04.001_bib45","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-scale CRISPR-Cas9 knockout screening in human cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ophtha.2018.04.001_bib46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2217\/nnm.13.204","article-title":"Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine","volume":"9","author":"Xue","year":"2014","journal-title":"Nanomedicine (Lond)"},{"issue":"5","key":"10.1016\/j.ophtha.2018.04.001_bib47","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/hum.2010.140","article-title":"AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa","volume":"22","author":"Mao","year":"2011","journal-title":"Hum Gene Ther"},{"issue":"6","key":"10.1016\/j.ophtha.2018.04.001_bib48","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ymthe.2005.08.008","article-title":"Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness","volume":"12","author":"Acland","year":"2005","journal-title":"Mol Ther"},{"issue":"20","key":"10.1016\/j.ophtha.2018.04.001_bib49","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1412965","article-title":"Improvement and decline in vision with gene therapy in childhood blindness","volume":"372","author":"Jacobson","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ophtha.2018.04.001_bib50","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/gt.2013.54","article-title":"Adeno-associated virus serotypes 9 and rh10 mediate strong neuronal transduction of the dog brain","volume":"21","author":"Swain","year":"2014","journal-title":"Gene Ther"},{"issue":"12","key":"10.1016\/j.ophtha.2018.04.001_bib51","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/mt.2015.177","article-title":"BEST1: the best target for gene and cell therapies","volume":"23","author":"Yang","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/j.ophtha.2018.04.001_bib52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.preteyeres.2017.01.006","article-title":"Bestrophin 1 and retinal disease","volume":"58","author":"Johnson","year":"2017","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"10.1016\/j.ophtha.2018.04.001_bib53","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1085\/jgp.200509473","article-title":"The light peak of the electroretinogram is dependent on voltage-gated calcium channels and antagonized by bestrophin (best-1)","volume":"127","author":"Marmorstein","year":"2006","journal-title":"J\u00a0Gen Physiol"},{"issue":"5","key":"10.1016\/j.ophtha.2018.04.001_bib54","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11897-016-0300-1","article-title":"Newer therapies for amyloid cardiomyopathy","volume":"13","author":"Chakraborty","year":"2016","journal-title":"Curr Heart Fail Rep"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642017336084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642017336084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:06:06Z","timestamp":1758981966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642017336084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0161642017336084"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.001","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clustered Regularly Interspaced Short Palindromic Repeats-Based Genome Surgery for the Treatment of Autosomal Dominant Retinitis Pigmentosa","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}